Institute for Health Metrics and Evaluation
The Institute for Health Metrics and Evaluation (IHME) is a research institute working in the area of global health statistics and impact evaluation at the University of Washington in Seattle. The Institute is headed by Christopher J.L. Murray, a physician and health economist, and professor at the University of Washington Department of Global Health, which is part of the School of Medicine. IHME conducts research and trains scientists, policymakers, and the public in health metrics concepts, methods, and tools. Its mission includes judging the effectiveness and efficacy of health initiatives and national health systems.[1][2] IHME also trains students at the post-baccalaureate and post-graduate levels.
"IHME" redirects here. For other uses, see IHME (disambiguation).Abbreviation
IHME
2007
Global health research institute
Accelerating global health progress through sound measurement and accountable science
2301 5th Ave, Suite 600
- Seattle, Washington, U.S.
In 2020, IHME published its model projecting deaths from the COVID-19 pandemic in the US, and informed guidelines developed by the Trump administration.
History[edit]
IHME was launched in June 2007 on a core grant of $105 million primarily funded by the Bill & Melinda Gates Foundation.[3] Among its earliest projects was to produce new estimates of mortality rates, which were published in The Lancet in September 2007.[4] The Institute updated these in 2010[5] and again in 2014.[6] It has published maternal,[7] child, and adult mortality[8] estimates as well.[9][10] Founding board members included Chair Julio Frenk, Dean of the Harvard School of Public Health; Harvey Fineberg, President of the Institute of Medicine; Gro Harlem Brundtland, former Prime Minister of Norway; Tedros Adhanom Ghebreyesus, the Minister of Health for Ethiopia; K. Srinath Reddy, President of the Public Health Foundation of India; Tomris Turmen, President of the International Children's Center and Head of the Department of Pediatrics/Newborn Medicine at the University of Ankara Medical School in Ankara, Turkey; Lincoln Chen, President of the China Medical Board; Jane Halton, who has served as Secretary of the Department of Health and Ageing in Australia, as well as the Department of Finance; and David Roux, Co-Chief Executive of Silver Lake Partners.[11]
IHME's current board members[12] are Frenk; Fineberg; Chen; Halton; and Roux, in addition to Stephen J. Cucchiaro, Chief Investment Officer of Windhaven Investment Management; Sally Davies, Chief Medical Officer (CMO) for England; and John W. Stanton, managing director of Trilogy Partnership.[13]
In 2011, IHME co-sponsored the first Global Health Metrics & Evaluation conference in Seattle with The Lancet, London School of Hygiene & Tropical Medicine, Harvard School of Public Health, and University of Queensland School of Population Health.[14]
In 2017, the Gates Foundation provided IHME with another $279 million grant.[15]
Degree Programs[edit]
IHME offers two types of global health fellowships, plus master's degrees and PhD programs.[60]
Funders[edit]
IHME receives core grant funding from the Bill & Melinda Gates Foundation[61] and the state of Washington. The US Centers for Disease Control and Prevention (CDC); Inter-American Development Bank; Gavi, the Vaccine Alliance; the National Heart, Lung and Blood Institute; Kingdom of Saudi Arabia Ministry of Health; Medtronic Philanthropy; and the National Institute on Aging have also contributed funding through project grants and contracts.
Reception[edit]
Initially, some within the World Health Organization had criticized IHME for trying to do the work that WHO already does. There had also been tension between UNICEF and IHME because a report from the latter showed "lackluster progress" on child death rates.[2][15]
In May 2018, WHO and IHME signed a memorandum of understanding, agreeing to strengthen collaboration on the GBD and enhance policy use of GBD findings.[37]